Cargando…
Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?
Renewing interest in immune aspects of schizophrenia and new findings about the brain-fat axis encourage us to discuss the possible role of interleukin-6 (IL-6) in schizophrenia. Previously, it was suggested that a primary alteration of the innate immune system may be relevant in schizophrenia. Func...
Autores principales: | Borovcanin, Milica Milovan, Jovanovic, Ivan, Radosavljevic, Gordana, Pantic, Jelena, Minic Janicijevic, Slavica, Arsenijevic, Nebojsa, Lukic, Miodrag L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681495/ https://www.ncbi.nlm.nih.gov/pubmed/29163240 http://dx.doi.org/10.3389/fpsyt.2017.00221 |
Ejemplares similares
-
Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia
por: Borovcanin, Milica M., et al.
Publicado: (2022) -
IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis
por: Borovcanin, Milica M., et al.
Publicado: (2018) -
Type 17 Immune Response Facilitates Progression of Inflammation and Correlates with Cognition in Stable Schizophrenia
por: Borovcanin, Milica M., et al.
Publicado: (2020) -
Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition
por: Minic Janicijevic, Slavica, et al.
Publicado: (2022) -
The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents
por: Pantic, Jelena M., et al.
Publicado: (2017)